✦ LIBER ✦

970 PROSPECT: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 EFFICACY TRIAL OF PROSTVAC-VF IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

✍ Scribed by Gulley, James; Gabrail, Nashat; Vogelzang, Nicholas; Rainwater, Leslie; Blitz, Barry; Hodge, Gameel; Lipsitz, David; Shore, Neal; Sieber, Paul; Stewart, Simon; Crabb, Simon; Bandman, Olga; Delcayre, Alain; Goessl, Carsten; Laus, Reiner; Schlom, Jeffrey; Kantoff, Philip

Book ID: 123301823
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 123 KB
Volume: 189
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.02.551

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and dasatinib or placebo in me

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

✍ Araujo, John C; Trudel, Géralyn C; Saad, Fred; Armstrong, Andrew J; Yu, Evan Y; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 703 KB

A Trial Postmortem: Challenges in Conduc

A Trial Postmortem: Challenges in Conducting a Randomized, Double-blind, Phase 2 Study in Men with Castration-resistant Prostate Cancer

✍ Daniel M. Geynisman; Russell Z. Szmulewitz; Walter M. Stadler 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 743 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

✍ Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 190 KB

Aflibercept versus placebo in combinatio

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB

Re: Aflibercept versus Placebo in Combin

Re: Aflibercept versus Placebo in Combination with Docetaxel and Prednisone for Treatment of Men with Metastatic Castration-Resistant Prostate Cancer (VENICE): A Phase 3, Double-Blind Randomised Trial

✍ Taneja, Samir S. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 59 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer

✍ Dreicer, Robert; Garcia, Jorge; Rini, Brian; Vogelzang, Nicholas; Srinivas, Sand 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 196 KB